Schonfeld Strategic Advisors LLC Legend Biotech Corp Transaction History

Schonfeld Strategic Advisors LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$63.16 - $76.5 $915,820 - $1.11 Million	14,500 New	14,500 $973,000
Q1 2023 May 15, 2023	SELL	$43.42 - $57.37 $286,572 - $378,642	-6,600 Reduced 47.83%	7,200 $347,000
Q4 2022 Feb 14, 2023	SELL	$38.8 - $55.46 $259,959 - $371,582	-6,700 Reduced 32.68%	13,800 $688,000
Q3 2022 Nov 14, 2022	SELL	$38.15 - $57.1 $2.18 Million - $3.27 Million	-57,232 Reduced 73.63%	20,500 $836,000
Q2 2022 Aug 15, 2022	BUY	$33.54 - $55.0 $295,084 - $483,890	8,798 Added 12.76%	77,732 $4.28 Million
Q1 2022 May 16, 2022	BUY	$31.02 - $48.18 $2.14 Million - $3.32 Million	68,934 New	68,934 $2.51 Million
Q4 2021 Feb 14, 2022	SELL	$41.14 - $56.98 $2.28 Million - $3.15 Million	-55,303 Closed	0 $0
Q3 2021 Nov 16, 2021	BUY	$35.31 - $50.56 $1.05 Million - $1.5 Million	29,737 Added 116.31%	55,303 $2.8 Million
Q2 2021 Aug 16, 2021	BUY	$25.8 - $41.09 $659,602 - $1.05 Million	25,566 New	25,566 $1.05 Million

212

77.9M

412K

387K

Ticker LEGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 167,403,008
Market Cap $6.73B
Description
Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multipl...

Get notified when there are updates to the investment portfolio of Schonfeld Strategic Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Schonfeld Strategic Advisors LLC with notifications on news.